SCHEMBL3779014

SCHEMBL3779014

Fc1ccc(F)c(-c2cccc(-c3ccccn3)c2)c1.Fc1ccc(F)c(-c2cccc(-c3ccccn3)c2)c1.Fc1ccc(F)c(-c2cccc(-c3ccccn3)c2)c1.[Ir]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.59
TGFBR1 P36897 4/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
KAT6A Q92794 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
MAPK14 Q16539 1/20 0.40
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40
CBFB Q13951 1/20 0.40
CDC7 O00311 1/20 0.40
ROCK2 O75116 1/20 0.40
MAP4K4 O95819 1/20 0.40
PIM1 P11309 1/20 0.40
PRKACA P17612 1/20 0.40
CDK2 P24941 1/20 0.40
GSK3B P49841 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3773686 0.88 GRM5 (0.47) GRM5TGFBR1RAB9AKAT6AMAPK14
SCHEMBL29397311 0.86 GRM5 (0.48) GRM5TGFBR1RAB9AKAT6AMAPK14
SCHEMBL17311166 0.86 GRM5 (0.48) GRM5TGFBR1RAB9AKAT6AMAPK14
SCHEMBL3773646 0.86 TGFBR1 (0.50) GRM5TGFBR1KDM4EALDH1A1MAPK1
SCHEMBL2483821 0.84 TGFBR1 (0.51) GRM5TGFBR1KDM4EALDH1A1MAPK1
SCHEMBL2692720 0.83 GRM5 (0.54) GRM5TGFBR1KDM4EALDH1A1MAPK1
SCHEMBL3767444 0.82 GRM5 (0.57) GRM5KDM4EMAPK1LMNAHTT
SCHEMBL4026544 0.82 GRM5 (0.60) GRM5KDM4EMAPK1LMNAHTT
SCHEMBL5845698 0.82 GRM5 (0.51) GRM5TGFBR1KDM4EALDH1A1MAPK1
SCHEMBL28463441 0.81 TOP1 (0.51) GRM5TGFBR1KDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8603645-B2 Stable and efficient electroluminescent materials UNIVERSAL DISPLAY CORPORATION (US) 2013-12-10 US disclosed
US-8449990-B2 Electroluminescent efficiency UNIVERSAL DISPLAY CORPORATION (US) 2013-05-28 US disclosed
US-20110060143-A1 Stable and Efficient Electroluminescent Materials KWONG RAYMOND 2011-03-10 US disclosed
US-7851072-B2 Stable and efficient electroluminescent materials UNIVERSAL DISPLAY CORPORATION (US) 2010-12-14 US disclosed
US-20070003789-A1 Stable and efficient electroluminescent materials UNIVERSAL DISPLAY CORPORAITON 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110060143-A1 Stable and Efficient Electroluminescent Materials EML4, ITGA5, CHRM5 GRM5 38/4885TGFBR1 2435/4885KDM4E 976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.